Aceso Life Science Group Balance Sheet Health
Financial Health criteria checks 3/6
Aceso Life Science Group has a total shareholder equity of HK$1.8B and total debt of HK$2.7B, which brings its debt-to-equity ratio to 150%. Its total assets and total liabilities are HK$4.8B and HK$3.0B respectively.
Key information
150.0%
Debt to equity ratio
HK$2.72b
Debt
| Interest coverage ratio | n/a |
| Cash | HK$469.00m |
| Equity | HK$1.81b |
| Total liabilities | HK$2.97b |
| Total assets | HK$4.79b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 474's short term assets (HK$1.3B) do not cover its short term liabilities (HK$2.2B).
Long Term Liabilities: 474's short term assets (HK$1.3B) exceed its long term liabilities (HK$759.0M).
Debt to Equity History and Analysis
Debt Level: 474's net debt to equity ratio (124.1%) is considered high.
Reducing Debt: 474's debt to equity ratio has increased from 90.6% to 150% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 474 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 474 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 39% each year